Applied Therapeutics Stock Investor Sentiment
| APLT Stock | USD 0.50 0.01 1.96% |
Slightly above 68% of Applied Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Applied Therapeutics suggests that many traders are alarmed. Applied Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Applied Therapeutics' earnings reports, geopolitical events, and overall market trends.
Comfort Level 32
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Applied Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Applied Therapeutics.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
Applied Historical Sentiment
Although Applied Therapeutics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Applied, such as negative comments on social media and news outlets, may cause fear in the market and push Applied Therapeutics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Applied.
Applied |
Applied Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Applied Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Applied Therapeutics Historical Investor Sentiment
Investor biases related to Applied Therapeutics' public news can be used to forecast risks associated with an investment in Applied. The trend in average sentiment can be used to explain how an investor holding Applied can time the market purely based on public headlines and social activities around Applied Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Applied Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Applied Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Applied Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Applied Therapeutics.
Far too much social signal, news, headlines, and media speculation about Applied Therapeutics that are available to investors today. That information is available publicly through Applied media outlets and privately through word of mouth or via Applied internal channels. However, regardless of the origin, that massive amount of Applied data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Applied Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Applied Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Applied Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Applied Therapeutics alpha.
Applied Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | INVESTOR ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Applied ... | 02/04/2025 |
2 | DEADLINE ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Applied ... | 02/12/2025 |
3 | JANUS HENDERSON GROUP PLC Significantly Reduces Stake in Applied Therapeutics Inc | 02/14/2025 |
4 | FINAL DEADLINE ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics | 02/18/2025 |
5 | Applied therapeutics COO Constantine Chinoporos sells 196 in stock - Investing.com | 03/06/2025 |
6 | Acquisition by Shoshana Shendelman of 1100000 shares of Applied Therapeutics subject to Rule 16b-3 | 03/10/2025 |
7 | APPLIED THERAPEUTICS Earnings Preview Recent APLT Insider Trading, Hedge Fund Activity, and More - Nasdaq | 03/12/2025 |
8 | Disposition of 16500 shares by Marcus Joel S of Applied Therapeutics at 1.05 subject to Rule 16b-3 | 03/17/2025 |
9 | Acquisition by Adam Hansard of 300000 shares of Applied Therapeutics subject to Rule 16b-3 | 03/18/2025 |
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.